No coin nor oath required. For personal study only.
Pharmaceuticals (MIC: 9.1 SIC: 2834 NAIC: 325412)
Eli Lilly is engaged primarily in the discovery, development, manufacture, and sale of pharmaceutical products. Co.'s principal products are: Neurosciences products, which includes Zyprexa®, Strattera®, Prozac®, Cymbalta® and Symbyax®; Endocrinology products, including Humalog®, Humalog Mix 75/25®, and Humalog Mix 50/50™, Humulin®, Actos®, Byetta®, Evista®, Humatrope®, and Forteo®; Oncology products, including Gemzar® and Alimta®; Cardiovascular products, including Cialis®, ReoPro® and Xigris®; and other pharmaceutical products, including Vancocin® and Ceclor®. Co. also has an animal health segment.
📜 SIMILAR VOLUMES
## Abstract **Pharmaceuticals (MIC: 9.1 SIC: 2834 NAIC:325412)** Eli Lilly discovers, develops, manufactures, and sells pharmaceuticals and animal health products. Neuroscience products include __Prozac__®, __Zyprexa__®, __Strattera__™__Darvon__®, __Permax__®, __Symbyax__®and __Sarafem__™. Endocri